| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk, Human | 59 | 2025 | 158 | 14.220 |
Why?
|
| Breast Feeding | 56 | 2025 | 137 | 12.060 |
Why?
|
| Infant, Very Low Birth Weight | 50 | 2022 | 154 | 10.700 |
Why?
|
| Intensive Care Units, Neonatal | 59 | 2025 | 173 | 9.570 |
Why?
|
| Infant, Premature | 60 | 2025 | 182 | 8.760 |
Why?
|
| Mothers | 40 | 2025 | 161 | 8.180 |
Why?
|
| Infant, Newborn | 109 | 2025 | 572 | 6.230 |
Why?
|
| Lactation | 23 | 2023 | 51 | 5.140 |
Why?
|
| Breast Milk Expression | 13 | 2020 | 33 | 4.890 |
Why?
|
| Infant Nutritional Physiological Phenomena | 28 | 2025 | 64 | 3.140 |
Why?
|
| Intensive Care, Neonatal | 11 | 2020 | 30 | 3.140 |
Why?
|
| Infant | 30 | 2025 | 520 | 2.190 |
Why?
|
| Enterocolitis, Necrotizing | 11 | 2020 | 36 | 2.100 |
Why?
|
| Female | 80 | 2025 | 14161 | 1.900 |
Why?
|
| Mother-Child Relations | 7 | 2017 | 28 | 1.760 |
Why?
|
| Humans | 112 | 2025 | 25165 | 1.750 |
Why?
|
| Child Development | 10 | 2020 | 65 | 1.580 |
Why?
|
| Infant, Premature, Diseases | 7 | 2020 | 26 | 1.510 |
Why?
|
| Neonatal Nursing | 12 | 2018 | 19 | 1.460 |
Why?
|
| Gestational Age | 16 | 2020 | 76 | 1.350 |
Why?
|
| Peer Group | 6 | 2017 | 31 | 1.340 |
Why?
|
| Social Support | 6 | 2019 | 191 | 1.220 |
Why?
|
| Maternal Behavior | 4 | 2017 | 10 | 1.210 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2019 | 15 | 1.130 |
Why?
|
| Adult | 38 | 2025 | 7259 | 1.090 |
Why?
|
| Milk Banks | 6 | 2020 | 18 | 1.010 |
Why?
|
| Patient Discharge | 9 | 2025 | 137 | 1.010 |
Why?
|
| Health Care Costs | 5 | 2020 | 70 | 1.000 |
Why?
|
| Bottle Feeding | 8 | 2016 | 14 | 1.000 |
Why?
|
| Prospective Studies | 19 | 2019 | 1618 | 0.990 |
Why?
|
| Counseling | 5 | 2013 | 40 | 0.890 |
Why?
|
| Postpartum Period | 3 | 2021 | 21 | 0.870 |
Why?
|
| Goals | 4 | 2017 | 38 | 0.850 |
Why?
|
| Infant, Low Birth Weight | 7 | 2019 | 16 | 0.830 |
Why?
|
| Male | 38 | 2025 | 13815 | 0.830 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2020 | 12 | 0.800 |
Why?
|
| Precision Medicine | 1 | 2022 | 22 | 0.800 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 294 | 0.750 |
Why?
|
| Postnatal Care | 2 | 2013 | 6 | 0.720 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 82 | 0.700 |
Why?
|
| Educational Status | 5 | 2019 | 273 | 0.700 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 30 | 0.690 |
Why?
|
| Nutritive Value | 5 | 2020 | 23 | 0.680 |
Why?
|
| Health Promotion | 4 | 2013 | 141 | 0.660 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 23 | 0.660 |
Why?
|
| Enteral Nutrition | 4 | 2018 | 61 | 0.660 |
Why?
|
| Contraception Behavior | 1 | 2019 | 4 | 0.640 |
Why?
|
| Sepsis | 3 | 2019 | 109 | 0.620 |
Why?
|
| Anthropometry | 6 | 2007 | 32 | 0.600 |
Why?
|
| Hospitalization | 6 | 2019 | 284 | 0.580 |
Why?
|
| Birth Weight | 7 | 2020 | 38 | 0.570 |
Why?
|
| Stress, Psychological | 2 | 2019 | 229 | 0.550 |
Why?
|
| Chicago | 7 | 2017 | 916 | 0.540 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2019 | 229 | 0.540 |
Why?
|
| Child Language | 2 | 2017 | 17 | 0.540 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 25 | 0.530 |
Why?
|
| Infant Care | 6 | 2016 | 17 | 0.520 |
Why?
|
| Depression, Postpartum | 2 | 2017 | 14 | 0.520 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 5 | 0.490 |
Why?
|
| Infant Formula | 6 | 2020 | 18 | 0.490 |
Why?
|
| Retrospective Studies | 12 | 2025 | 3185 | 0.480 |
Why?
|
| Young Adult | 7 | 2019 | 1813 | 0.480 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 1301 | 0.480 |
Why?
|
| Cost Savings | 1 | 2015 | 29 | 0.480 |
Why?
|
| Weight Gain | 5 | 2018 | 58 | 0.460 |
Why?
|
| Energy Intake | 4 | 2018 | 77 | 0.460 |
Why?
|
| Suction | 3 | 2010 | 40 | 0.460 |
Why?
|
| Motor Activity | 2 | 2017 | 314 | 0.450 |
Why?
|
| Research Support as Topic | 2 | 2005 | 14 | 0.450 |
Why?
|
| Infant, Extremely Low Birth Weight | 3 | 2012 | 20 | 0.450 |
Why?
|
| Retinopathy of Prematurity | 1 | 2014 | 6 | 0.450 |
Why?
|
| Patient Education as Topic | 5 | 2013 | 122 | 0.450 |
Why?
|
| Intestines | 2 | 2013 | 76 | 0.440 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 171 | 0.440 |
Why?
|
| Hospital Costs | 1 | 2013 | 57 | 0.410 |
Why?
|
| Direct Service Costs | 1 | 2012 | 3 | 0.400 |
Why?
|
| Attitude to Health | 1 | 2013 | 94 | 0.400 |
Why?
|
| Perception | 2 | 2020 | 73 | 0.380 |
Why?
|
| Premature Birth | 2 | 2023 | 10 | 0.380 |
Why?
|
| Breast | 2 | 2008 | 24 | 0.370 |
Why?
|
| Risk Factors | 7 | 2016 | 2179 | 0.370 |
Why?
|
| Nurse's Role | 5 | 2007 | 59 | 0.370 |
Why?
|
| Reproducibility of Results | 10 | 2006 | 641 | 0.360 |
Why?
|
| United States | 10 | 2020 | 1928 | 0.340 |
Why?
|
| Incidence | 6 | 2020 | 704 | 0.340 |
Why?
|
| Nurseries, Hospital | 2 | 2007 | 3 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 243 | 0.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 153 | 0.310 |
Why?
|
| Cognition | 2 | 2017 | 1270 | 0.310 |
Why?
|
| Clinical Nursing Research | 2 | 2002 | 4 | 0.310 |
Why?
|
| Child, Preschool | 3 | 2020 | 609 | 0.310 |
Why?
|
| Diet | 3 | 2018 | 211 | 0.300 |
Why?
|
| Animals | 7 | 2020 | 3430 | 0.300 |
Why?
|
| Qualitative Research | 4 | 2017 | 111 | 0.300 |
Why?
|
| Lipids | 2 | 2006 | 47 | 0.300 |
Why?
|
| Child | 4 | 2021 | 1211 | 0.300 |
Why?
|
| Biomarkers | 3 | 2020 | 520 | 0.300 |
Why?
|
| Body Weight | 6 | 1996 | 128 | 0.290 |
Why?
|
| Anxiety | 2 | 2019 | 150 | 0.280 |
Why?
|
| Maternal Age | 3 | 2019 | 12 | 0.270 |
Why?
|
| Interviews as Topic | 3 | 2017 | 125 | 0.270 |
Why?
|
| Residence Characteristics | 2 | 2019 | 200 | 0.260 |
Why?
|
| Costs and Cost Analysis | 2 | 2019 | 33 | 0.260 |
Why?
|
| Maternal-Child Nursing | 2 | 2004 | 4 | 0.260 |
Why?
|
| Centrifugation | 1 | 2006 | 4 | 0.260 |
Why?
|
| Colostrum | 3 | 2010 | 4 | 0.250 |
Why?
|
| Decision Making | 4 | 2015 | 202 | 0.250 |
Why?
|
| Milk Ejection | 3 | 2011 | 3 | 0.240 |
Why?
|
| Research | 1 | 2005 | 36 | 0.240 |
Why?
|
| Adolescent | 7 | 2017 | 2018 | 0.240 |
Why?
|
| Child Nutrition Sciences | 1 | 2005 | 3 | 0.240 |
Why?
|
| Evidence-Based Practice | 2 | 2016 | 65 | 0.230 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 37 | 0.230 |
Why?
|
| Cohort Studies | 6 | 2020 | 1772 | 0.230 |
Why?
|
| Toxoplasmosis, Congenital | 3 | 2011 | 8 | 0.220 |
Why?
|
| Mass Media | 1 | 2004 | 10 | 0.220 |
Why?
|
| Nursing Evaluation Research | 4 | 2015 | 19 | 0.220 |
Why?
|
| Pregnancy | 7 | 2019 | 298 | 0.220 |
Why?
|
| Financing, Government | 1 | 2003 | 9 | 0.210 |
Why?
|
| Nutritional Status | 2 | 2020 | 53 | 0.210 |
Why?
|
| Parents | 1 | 2004 | 112 | 0.210 |
Why?
|
| Health Policy | 1 | 2003 | 41 | 0.200 |
Why?
|
| Aftercare | 3 | 2018 | 21 | 0.200 |
Why?
|
| Cost of Illness | 2 | 2013 | 48 | 0.200 |
Why?
|
| Nutritional Support | 3 | 2018 | 23 | 0.190 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 138 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2018 | 89 | 0.180 |
Why?
|
| Age Factors | 2 | 2020 | 712 | 0.180 |
Why?
|
| Health Expenditures | 1 | 2020 | 15 | 0.180 |
Why?
|
| Neonatology | 1 | 2020 | 3 | 0.180 |
Why?
|
| Protective Devices | 1 | 2000 | 2 | 0.170 |
Why?
|
| Nipples | 1 | 2000 | 5 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2021 | 71 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 114 | 0.170 |
Why?
|
| Linear Models | 3 | 2017 | 238 | 0.160 |
Why?
|
| Child of Impaired Parents | 1 | 2019 | 9 | 0.160 |
Why?
|
| Time Factors | 6 | 2018 | 1336 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 152 | 0.160 |
Why?
|
| Directive Counseling | 1 | 2019 | 10 | 0.160 |
Why?
|
| Intention | 1 | 2019 | 20 | 0.160 |
Why?
|
| Body Mass Index | 1 | 2021 | 428 | 0.160 |
Why?
|
| Acute Disease | 1 | 2019 | 165 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 42 | 0.160 |
Why?
|
| Inflammation | 2 | 2018 | 253 | 0.160 |
Why?
|
| Program Evaluation | 2 | 2013 | 109 | 0.160 |
Why?
|
| Obesity | 1 | 2021 | 291 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2018 | 390 | 0.150 |
Why?
|
| Return to Work | 2 | 2016 | 58 | 0.150 |
Why?
|
| Feeding Methods | 2 | 2013 | 5 | 0.150 |
Why?
|
| Social Class | 1 | 2019 | 64 | 0.150 |
Why?
|
| Depression | 2 | 2019 | 428 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2016 | 50 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 305 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1672 | 0.150 |
Why?
|
| Cell Death | 1 | 2018 | 44 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 72 | 0.140 |
Why?
|
| Sucking Behavior | 2 | 1994 | 2 | 0.140 |
Why?
|
| Nervous System | 1 | 2017 | 10 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 18 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 348 | 0.140 |
Why?
|
| Eating | 2 | 2011 | 52 | 0.140 |
Why?
|
| Pregnancy in Adolescence | 1 | 2017 | 10 | 0.140 |
Why?
|
| Narration | 1 | 2017 | 12 | 0.140 |
Why?
|
| Tissue and Organ Procurement | 1 | 2016 | 30 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 64 | 0.130 |
Why?
|
| Program Development | 2 | 2014 | 46 | 0.130 |
Why?
|
| Science | 1 | 1996 | 4 | 0.130 |
Why?
|
| Nurse-Patient Relations | 2 | 2015 | 44 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 836 | 0.130 |
Why?
|
| Weaning | 1 | 2016 | 4 | 0.130 |
Why?
|
| Nutrition Assessment | 1 | 1996 | 40 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 172 | 0.130 |
Why?
|
| Illinois | 1 | 2016 | 231 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 54 | 0.130 |
Why?
|
| Informed Consent | 1 | 2015 | 20 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 42 | 0.120 |
Why?
|
| Bacteria | 1 | 2016 | 64 | 0.120 |
Why?
|
| Nigeria | 2 | 2007 | 3 | 0.120 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2015 | 3 | 0.120 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 13 | 0.120 |
Why?
|
| Incubators, Infant | 2 | 1995 | 2 | 0.120 |
Why?
|
| Life Change Events | 1 | 2015 | 37 | 0.120 |
Why?
|
| Length of Stay | 1 | 2017 | 295 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2015 | 66 | 0.120 |
Why?
|
| Beds | 1 | 1994 | 3 | 0.110 |
Why?
|
| Home Nursing | 1 | 1994 | 33 | 0.110 |
Why?
|
| Nursing Staff, Hospital | 2 | 1993 | 22 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 50 | 0.110 |
Why?
|
| Focus Groups | 1 | 1994 | 82 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 450 | 0.110 |
Why?
|
| Milk | 2 | 2012 | 12 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2015 | 118 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 29 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 138 | 0.110 |
Why?
|
| Swine | 1 | 2013 | 65 | 0.110 |
Why?
|
| Models, Animal | 1 | 2013 | 111 | 0.110 |
Why?
|
| Clinical Chemistry Tests | 2 | 2006 | 5 | 0.110 |
Why?
|
| Guilt | 1 | 2013 | 5 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 1085 | 0.110 |
Why?
|
| Organizational Culture | 1 | 2013 | 16 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2014 | 128 | 0.100 |
Why?
|
| Propensity Score | 1 | 2013 | 35 | 0.100 |
Why?
|
| Motivation | 1 | 2013 | 81 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2012 | 6 | 0.100 |
Why?
|
| Microbiota | 1 | 2013 | 79 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 7 | 0.100 |
Why?
|
| Quadruplets | 1 | 1992 | 1 | 0.100 |
Why?
|
| Body Height | 1 | 1992 | 32 | 0.100 |
Why?
|
| Food Contamination | 1 | 2011 | 3 | 0.100 |
Why?
|
| Toxoplasma | 1 | 2011 | 6 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 120 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 182 | 0.090 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2010 | 4 | 0.090 |
Why?
|
| Lactoferrin | 1 | 2010 | 6 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3204 | 0.090 |
Why?
|
| Cultured Milk Products | 1 | 2009 | 2 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2020 | 149 | 0.080 |
Why?
|
| Models, Nursing | 2 | 2004 | 21 | 0.080 |
Why?
|
| Infant Food | 2 | 2004 | 2 | 0.080 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 41 | 0.070 |
Why?
|
| Equipment Design | 2 | 2007 | 132 | 0.070 |
Why?
|
| Observer Variation | 6 | 2000 | 89 | 0.070 |
Why?
|
| Midwifery | 1 | 2007 | 1 | 0.070 |
Why?
|
| Nursing Diagnosis | 1 | 2007 | 2 | 0.070 |
Why?
|
| Kenya | 1 | 2007 | 6 | 0.070 |
Why?
|
| Models, Biological | 1 | 2009 | 313 | 0.070 |
Why?
|
| Data Collection | 2 | 2002 | 87 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 241 | 0.070 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2006 | 2 | 0.070 |
Why?
|
| Vision Disorders | 1 | 2006 | 19 | 0.070 |
Why?
|
| North America | 2 | 2018 | 39 | 0.060 |
Why?
|
| Risk Management | 1 | 2005 | 5 | 0.060 |
Why?
|
| Ethics, Research | 1 | 2005 | 3 | 0.060 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Toxoplasmosis | 1 | 2005 | 5 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2005 | 19 | 0.060 |
Why?
|
| Object Attachment | 1 | 2004 | 1 | 0.060 |
Why?
|
| Prenatal Diagnosis | 1 | 2005 | 14 | 0.060 |
Why?
|
| Nursing Methodology Research | 1 | 2004 | 30 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2005 | 48 | 0.060 |
Why?
|
| Logistic Models | 2 | 2016 | 377 | 0.060 |
Why?
|
| Clinical Protocols | 2 | 2014 | 56 | 0.060 |
Why?
|
| Health Planning Support | 1 | 2003 | 1 | 0.050 |
Why?
|
| Healthy People Programs | 1 | 2003 | 2 | 0.050 |
Why?
|
| Databases, Bibliographic | 1 | 2003 | 7 | 0.050 |
Why?
|
| Policy Making | 1 | 2003 | 12 | 0.050 |
Why?
|
| Politics | 1 | 2003 | 11 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2003 | 25 | 0.050 |
Why?
|
| Conflict of Interest | 1 | 2003 | 12 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2003 | 208 | 0.050 |
Why?
|
| Holistic Nursing | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cross Infection | 1 | 2005 | 295 | 0.050 |
Why?
|
| Research Design | 1 | 2002 | 175 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 275 | 0.040 |
Why?
|
| Silicones | 1 | 2000 | 11 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 192 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2020 | 70 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2006 | 943 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1994 | 30 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 106 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2010 | 103 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 1996 | 94 | 0.040 |
Why?
|
| Oceania | 1 | 2018 | 2 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 8 | 0.040 |
Why?
|
| Africa | 1 | 2018 | 9 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 53 | 0.040 |
Why?
|
| Internationality | 1 | 2018 | 21 | 0.040 |
Why?
|
| North Carolina | 1 | 2018 | 11 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 318 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 557 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2018 | 8 | 0.040 |
Why?
|
| F2-Isoprostanes | 1 | 2018 | 6 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 43 | 0.040 |
Why?
|
| Income | 1 | 2018 | 77 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 89 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 184 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 33 | 0.030 |
Why?
|
| Health | 1 | 1996 | 9 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 39 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 46 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 37 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 47 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 88 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 8 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 14 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2015 | 9 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 167 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 105 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 251 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 77 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 1994 | 3 | 0.030 |
Why?
|
| Nurse Clinicians | 1 | 1994 | 9 | 0.030 |
Why?
|
| Research Personnel | 1 | 1994 | 19 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 1994 | 22 | 0.030 |
Why?
|
| Group Processes | 1 | 1994 | 13 | 0.030 |
Why?
|
| Consultants | 1 | 1993 | 1 | 0.030 |
Why?
|
| Workload | 1 | 1993 | 25 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 1 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 5 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 43 | 0.020 |
Why?
|
| Cesarean Section | 1 | 1992 | 29 | 0.020 |
Why?
|
| Fetal Development | 1 | 2012 | 3 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 65 | 0.020 |
Why?
|
| Oocysts | 1 | 2011 | 2 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2011 | 5 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1993 | 113 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 31 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 37 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 28 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1300 | 0.020 |
Why?
|
| Bodily Secretions | 1 | 2010 | 1 | 0.020 |
Why?
|
| Weights and Measures | 1 | 1990 | 3 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 12 | 0.020 |
Why?
|
| Cephalometry | 1 | 1989 | 4 | 0.020 |
Why?
|
| Trachea | 1 | 2010 | 39 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 1989 | 10 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 450 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 693 | 0.020 |
Why?
|
| Vision, Binocular | 1 | 2006 | 2 | 0.020 |
Why?
|
| Vision, Monocular | 1 | 2006 | 2 | 0.020 |
Why?
|
| Macula Lutea | 1 | 2006 | 3 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2006 | 10 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2006 | 16 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2006 | 38 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2006 | 18 | 0.020 |
Why?
|
| Language Tests | 1 | 2006 | 32 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2005 | 78 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2004 | 28 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 147 | 0.010 |
Why?
|
| Electronics | 2 | 1995 | 9 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 37 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2000 | 37 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2000 | 389 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 113 | 0.010 |
Why?
|
| Transducers, Pressure | 1 | 1992 | 4 | 0.010 |
Why?
|